Nusantara ramps up development of Awak Mas Gold Project

Published 12-DEC-2018 11:06 A.M.

|

4 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

On the heels of its recently completed definitive feasibility study (DFS), ASX junior Nusantara (ASX:NUS) has clinched another key milestone, securing a strategic Indonesian cornerstone investor with funds raised to help advance the Awak Mas Gold Project.

That investor is PT Indika Energy Tbk (IDX:INDY), a leading integrated energy and resources company listed on the Indonesian Stock Exchange, with strategic investments in energy resources, services and infrastructure.

Indika and Nusantara have entered into agreements defining an ongoing strategic relationship, which will focus on exploring avenues for completing the financing and development of the Awak Mas Gold Project, as well as making provisions for Indika to acquire an interest in the project (extent and nature of the interest to be agreed).

On completion of a A$10.25 million capital raising, Indika (via its wholly owned subsidiary PT Indika Minerals Investindo) will obtain a 19.9% interest in Nusantara and its existing shareholder, AustralianSuper Pty Ltd, will raise its stake to 14%.

The funds raised will help advance NUS's Awak Project, with the follow key terms, as laid out below:

  • NUS has entered into a subscription agreement for a placement of 30.6 million shares at 23 cents per share, for total funds A$$7.04 million with a subsidiary of Indika. Indika will obtain a 19.9% interest as a result.
  • Existing shareholder AustralianSuper has subscribed for 11.2 million shares at 23 cents per share. This placement will raise A$2.6 million and is subject to shareholder approval. AustralianSuper’s holding will rise to 14%.
  • Subject to shareholder approval, Indika will subscribe for a further 2.8 million shares at 23 cents per share totalling $0.64 million.
  • NUS’ major shareholder, Lion Selection Group (ASX:LSX), which holds 32.32%, supports both placements.
  • Indika and AustralianSuper will be issued options on a 1 for 2 pro-rata to their share subscriptions, these options will be exercisable at A$0.35 on or before November 2020.
  • In total, these placements will raise A$10.25 million, which will advance the development of the Awak Mas Gold Project through further optimisation studies, near-mine exploration, prep work and general working capital.

NUS managing director, Mike Spreadborough, commented on this latest development: “The board of Nusuntara welcomes Indika as a shareholder and looks forward to the contribution it will make to exploring avenues for the financing and development of the Awak Mas Gold Project.

“Indika’s investment in Nusantara is a significant milestone in progressing the project and demonstrates the value of this low cost, long life gold project and its exceptional exploration potential.

“Indika brings a wealth of Indonesian operation experience through its extensive resource and energy activities across Indonesia, and we look forward to the ongoing support and advice of Indika’s highly credentialed Board of Commissioners and Board of Directors.

“I’d also like to thank AustralianSuper for its ongoing support, which further validates the significant potential of Awak Mas.”

More about Indika

Indika's energy resources business pillar focuses on exploration, production and processing of coal.

Its energy services business, on the other hand, provides contract mining, engineering, procurement and construction as well as operations and maintenance.

On top of that, the energy infrastructure component of the business specialises in coal-fired power plants and provides marine transportation, logistics for bulk goods and natural resources.

Indika managing director and CEO, Azis Armand, commented: “We are excited to be part of Nusantara Resources and as a local partner, we look forward to working together with management to unlock the potential of the Awak Mas Gold Project.”

Some background on the Awak Mas Gold Project

Nusantara's Awak Mas Gold Project is located in South Sulawesi, Indonesia, with all approvals in place for development.

Awak Mas is one of just a few undeveloped gold projects within the Asia-Pacific region, and has an ore Reserve of 1.1 million ounces, within a 2.0 million-ounce Mineral Resource.

The recently completed DFS confirms that the project is technically feasible and financially robust, with significant opportunities to increase project value through optimising the current mineral resources and through further exploration.

The DFS supports an initial eleven-year project with the 2.5 Mtpa processing plant targeting annual gold production of around 100,000 ounces, delivering strong margins.

The mining operation will include two open pit mines with an initial 11-year life, and a low project strip ratio of 3.5.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X